VanEck Associates’s Synovus SNV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-18,346
Closed -$566K 1460
2023
Q1
$566K Buy
18,346
+13,560
+283% +$516K ﹤0.01% 987
2022
Q4
$180K Buy
4,786
+673
+16% +$26.7K ﹤0.01% 1127
2022
Q3
$154K Buy
4,113
+370
+10% +$14.7K ﹤0.01% 1082
2022
Q2
$135K Buy
3,743
+197
+6% +$8.15K ﹤0.01% 1154
2022
Q1
$174K Buy
3,546
+487
+16% +$24.7K ﹤0.01% 1129
2021
Q4
$146K Buy
3,059
+216
+8% +$10.2K ﹤0.01% 1171
2021
Q3
$125K Buy
2,843
+1,057
+59% +$44.7K ﹤0.01% 1109
2021
Q2
$78K Buy
+1,786
New +$83.9K ﹤0.01% 1129

Other funds holding SNV

VanEck Associates's SNV Position: Q2 2023 in Review

VanEck Associates sold out of Synovus (SNV) in Q2 2023, closing a stake of 18,346 shares — an estimated $566K sold.

VanEck Associates first reported a position in SNV in Q2 2021 and held it in 8 quarters. The position peaked at $566K in Q1 2023. 370 funds tracked by Wall St. Rank hold SNV as of Q2 2023.

  • VanEck Associates reported no remaining Synovus position as of Q2 2023 after selling out during the quarter.
  • VanEck Associates sold 18,346 Synovus shares in Q2 2023, an estimated $566K.
  • VanEck Associates first reported a position in Synovus in Q2 2021 and held it in 8 quarters.
  • VanEck Associates's Synovus position peaked at $566K in Q1 2023.
  • 370 funds tracked by Wall St. Rank held Synovus as of Q2 2023.

Based on VanEck Associates's 13F filing for Q2 2023, filed 3 Aug 2023.